Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Search Results: immunotherapy

Showing 12 out of 568 results
Cancer Research UK logo

CANCER RESEARCH UK scientists at the University of Southampton have developed a potential new antibody treatment which, in the laboratory, shows significantly increased survival from neuroblastoma - a form of childhood cancer which grows from undeveloped tissue of the nervous system. It is hoped that it could one day be used to treat children with the disease. Their findings will be presented at the NCRI Cancer Conference in Birmingham. CANCER RESEARCH UK scientists at the University of Southampton have developed a potential new antibody treatment which, in the laboratory, shows significantly increased survival from neuroblastoma - a form of childhood cancer which grows from undeveloped tissue of the nervous system. It is hoped that it could one day be used to treat children with the disease. Their findings will be presented at the NCRI Cancer Conference in Birmingham.

by The National Cancer Research Institute (NCRI) | News | 5 October 2009

5 October 2009

A microscope image showing purple cancer cells against a black background.

PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns. PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns.

by Amal Iman, Tim Gunn | News | 10 April 2025

10 April 2025

Microscope image of human colon cancer cells
  • Science & Technology
  • Health & Medicine

Bowel cancer awareness month: Common questions answered

To help raise awareness around bowel cancer, and the research we are doing, we’re answering some the most common questions on bowel cancer. To help raise awareness around bowel cancer, and the research we are doing, we’re answering some the most common questions on bowel cancer.

by Amy Warnock | In depth | 1 April 2025

1 April 2025

Microscopic images of pleural fluid cytology of a small cell oat cell carcinoma
  • Science & Technology
  • Health & Medicine

12 ways we’ve influenced progress in lung cancer 

From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 12 ways we have worked towards progress in lung cancer. From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 12 ways we have worked towards progress in lung cancer.

by Amy Warnock | 31 October 2024

31 October 2024

stained microscopic sample of stomach cancer cells

The immunotherapy drug pembrolizumab (also known as Keytruda) has been approved as an option for people with advanced gastric cancer. The immunotherapy drug pembrolizumab (also known as Keytruda) has been approved as an option for people with advanced gastric cancer.

by Sophie Wedekind | News | 7 August 2024

7 August 2024

Adendra Therapeutics want to create a new kind of immunotherapy using novel insights into dendritic cell biology. We spoke to co-founder and CEO Raj Mehta about the road to commercialisation. Adendra Therapeutics want to create a new kind of immunotherapy using novel insights into dendritic cell biology. We spoke to co-founder and CEO Raj Mehta about the road to commercialisation.

by Tim Bodicoat | Interview | 26 April 2023

26 April 2023